A novel exosome-based theragnostic system

Exhibitor: NATIONAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY

Booth No: N313A

Characteristic

The technology aims to develop an Novel multi-module non-invasive delivery platform to enhance the delivery efficiency and stability of exosome-encapsulated drugs such as RNA. Key features of the system include:

• Disposable dry powder-type microbubble drug carriers for convenient clinical use;
• Compliance with FDA safety regulations, offering multi-frequency, safe, and efficient performance;
• Integration with a cloud platform and smart display interface, facilitating parameter control and the development of remote diagnosis and treatment.

This "novel exosome-integrated cavitation-effect diagnostic and therapeutic system" holds significant market potential. By utilizing microbubble carriers for localized drug release, it supports anti-aging treatments and interventions for neurodegenerative diseases, while offering advantages such as room-temperature storage, real-time monitoring, intelligent feedback, and remote control.

The system can automatically adjust treatment parameters based on disease type and location to ensure optimal drug penetration and therapeutic outcomes. Furthermore, it enables guided ultrasound-targeted release and non-invasive drug delivery via the nasopharynx and round window membrane, enhancing both safety and precision.

With applications spanning medical aesthetics, neurotherapy, and smart medical devices, this technology demonstrates strong commercialization and clinical adoption potential, positioning it as a key tool in the future of precision medicine.